We also found moderate evidence from human studies that increasing IGF-I levels increases prostate cancer and advanced prostate cancer risk, and low-level evidence of no effect of IGFBP-3 levels on prostate cancer and advanced prostate cancer risk. The gene discussed is IGFBP3; the disease is prostate cancer.